Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ribosomal protein L6 pseudogene 4 is a processed pseudogene related to the gene encoding 60S ribosomal protein L6. Pseudogenes like RPL6P4 arise from duplication or retrotransposition events and are typically non-functional, lacking the ability to produce a functional protein product. RPL6P4 is one of numerous processed pseudogenes homologous to functional ribosomal protein genes in the human genome[5]. There is no evidence that RPL6P4 is transcribed or translated into a functional protein, nor that it serves as a therapeutic target. Its primary significance is as a genetic marker of evolutionary processes affecting ribosomal protein genes[4][5].\n\nKey facts:\n- This pseudogene contains sequence homology to the ribosomal protein L6 gene (RPL6), but does not encode a functional ribosomal protein[4][5].\n- RPL6P4 is not implicated in disease, drug interaction, or cellular regulatory processes, nor is it a biomarker or safety concern.\n- The functional ribosomal protein L6 (gene symbol RPL6) is a bona fide protein component of the 60S ribosomal subunit, but RPL6P4 is not, and thus should not be used as a therapeutic target identifier[1][3][4].\n\nIf your intent was to refer to the functional ribosomal protein L6, see "RPL6" instead, which is a structurally and functionally characterized ribosomal protein, but "RPL6P4" itself is non-coding and not a molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ribosomal protein L6 pseudogene 4 (RPL6P4).